3D.01: VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF STROKE OR CARDIAC EVENTS IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE VALUE TRIAL.

Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States. PLoS Med (2015) 1.80

Moods in Clinical Depression Are More Unstable than Severe Normal Sadness. Front Psychiatry (2017) 0.75

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet (1998) 26.64

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet (2007) 14.96

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34

Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA (1999) 5.76

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet (2000) 4.93

Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ (2001) 4.66

General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet (2008) 4.18

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet (2000) 4.09

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50

Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ (2004) 3.47

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension (1990) 3.30

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators. Lancet (1997) 3.30

Very early risk of stroke after a first transient ischemic attack. Stroke (2003) 3.26

Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension (1989) 3.13

Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91

1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72

Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study. Neurology (2011) 2.62

Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation (2006) 2.53

Changes in physical fitness and changes in mortality. Lancet (1998) 2.40

Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology (2004) 2.36

Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology (2010) 2.34

Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2003) 2.21

Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens (1987) 2.21

Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet (1983) 2.18

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17

Arterial stiffness. J Hypertens (1999) 2.16

Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16

Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumors. BMC Genomics (2008) 2.11

Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am J Physiol Regul Integr Comp Physiol (2001) 2.09

Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. J Clin Epidemiol (2010) 2.08

Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke (2004) 2.08

Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation (2001) 2.08

Incidence and prognosis of > or = 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain (2009) 2.08

European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06

Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension (1995) 2.04

The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03

How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens (2000) 2.02

Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol (2007) 2.02

Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality. Eur Heart J (2000) 2.01

Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01

Direct assessment of completeness of ascertainment in a stroke incidence study. Stroke (2004) 1.99

Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98

Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke (2003) 1.93

Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93

Prognostic value of 24-hour blood pressure variability. J Hypertens (1993) 1.84

Evidence of underdiagnosis of myasthenia gravis in older people. J Neurol Neurosurg Psychiatry (2003) 1.84

Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80

Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension (1987) 1.80

Systematic review of the risks of carotid endarterectomy in relation to the clinical indication for and timing of surgery. Stroke (2003) 1.79

Sympathetic activation in obese normotensive subjects. Hypertension (1995) 1.78

The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry (2003) 1.78

A new approach to analysis of the arterial baroreflex. J Hypertens Suppl (1985) 1.76

Prazosin: preliminary report and comparative studies with other antihypertensive agents. Br Med J (1974) 1.76

Angiographically defined collateral circulation and risk of stroke in patients with severe carotid artery stenosis. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Stroke (2000) 1.75

Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res (1983) 1.74

A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis (2005) 1.74

Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens (1998) 1.73

Home blood pressure monitoring. Arch Intern Med (2000) 1.71

Number and spatial distribution of nuclei in the muscle fibres of normal mice studied in vivo. J Physiol (2003) 1.69

Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension (1988) 1.69

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia (2005) 1.69

Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67

Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke (2003) 1.64

Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol (1988) 1.64

Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64

High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation (1998) 1.60

Overview of the principal results and secondary analyses from the European and North American randomised trials of endarterectomy for symptomatic carotid stenosis. Eur J Vasc Endovasc Surg (2003) 1.59

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension (1998) 1.58

Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57

Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57

Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56

Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens (2007) 1.55

Broad-band spectral analysis of 24 h continuous finger blood pressure: comparison with intra-arterial recordings. Clin Sci (Lond) (1999) 1.52

Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51

Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51

Population-based study of delays in carotid imaging and surgery and the risk of recurrent stroke. Neurology (2005) 1.51

Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension (1998) 1.51

[Arterial hypertension and cardiac pathology. Diagnostic and therapeutic guidelines presented by the Joint Commission of the ANMCO-SIC-SIIA. Assoziane Nazionale Medici Cardiologi Ospedalieri. Società Italiana di Cardiologia. Società Italiana dell'Ipertensione Arteriosa]. G Ital Cardiol (1999) 1.50

Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49

Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther (1980) 1.49

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators. J Hypertens (2001) 1.49

Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48

Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46

Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation (1994) 1.45

Time and frequency domain estimates of spontaneous baroreflex sensitivity provide early detection of autonomic dysfunction in diabetes mellitus. Diabetologia (1997) 1.45

Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45

Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med (1977) 1.45

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44